Pre-clinical study of drug combinations that reduce breast cancer burden due to aberrant mTOR and metabolism promoted by LKB1 loss (Q35149656)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Pre-clinical study of drug combinations that reduce breast cancer burden due to aberrant mTOR and metabolism promoted by LKB1 loss |
scientific article |
Statements
1 reference
Pre-clinical study of drug combinations that reduce breast cancer burden due to aberrant mTOR and metabolism promoted by LKB1 loss (English)
1 reference
Paola A Marignani
1 reference
Rafaela Andrade-Vieira
1 reference
Donna Goguen
1 reference
Heidi A Bentley
1 reference
Chris V Bowen
1 reference
1 December 2014
1 reference
1 reference
1 reference
1 reference